Medipharm Labs Corp (OP: MEDIF )

0.0515 +0.0009 (+1.78%)

Streaming Delayed Price Updated: 9:45 AM EDT, Oct 8, 2024 Add to My Watchlist

Price and Volume

Volume	2,697
Open	0.0506
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.0506
Today's Range	0.0515 - 0.0515
52wk Range	0.0374 - 0.0747
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

MEDIF Stock Earnings: MediPharm Labs Reported Results for Q2 2024

August 14, 2024

MediPharm Labs just reported results for the second quarter of 2024.

Via InvestorPlace

MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY

August 14, 2024

Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday financial results for the second quarter ended June 30, 2024, revealing an...

Via Benzinga

Performance

YTD	+4.46%	+4.46%
1 Month	+8.65%	+8.65%
3 Month	+0.59%	+0.59%
6 Month	-18.25%	-18.25%
1 Year	-4.98%	-4.98%

More News

The Canadian Cannabis Report- Monday, Aug 12

August 13, 2024

Via Talk Markets

This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now

August 09, 2024

Via Benzinga

MEDIF Stock Earnings: MediPharm Labs Reported Results for Q1 2024

May 15, 2024

Via InvestorPlace

MEDIF Stock Earnings: MediPharm Labs Reported Results for Q4 2023

March 27, 2024

Via InvestorPlace

Executive Changes In Cannabis Industry You Should Know About, New Appointments & More

July 03, 2024

Via Benzinga

Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method

June 20, 2024

Via Benzinga

Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position'

May 15, 2024

Via Benzinga

The Canadian Cannabis Report - Monday, April 22

April 22, 2024

Via Talk Markets

This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses

March 27, 2024

Via Benzinga

The Canadian Cannabis Report - Monday, March 25

March 27, 2024

Via Talk Markets

Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil

February 07, 2024

Via Benzinga

Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024

December 22, 2023

Via Benzinga

MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report

November 14, 2023

Via Benzinga

New Cannabis Products Energize Global Health & Wellness Market, Including Australia

October 16, 2023

Via Benzinga

MediPharm Settles Commercial Agreement Dispute With Tilray's Hexo For $9M

October 02, 2023

Via Benzinga

New CBD & THC Cannabis Oils Now Shipping To Australia From Canada

September 28, 2023

Via Benzinga

The Canadian Cannabis Report - Monday, Sept. 25

September 25, 2023

Via Talk Markets

MediPharm Labs Breaks Free From Royalty Agreement, What It Means & What's Next

September 20, 2023

Via Benzinga

Could Medical Cannabis Be The Answer For Fibromyalgia? Here's What New Study Found

August 31, 2023

Via Benzinga

Cannabis Stock Gainers And Losers From August 24, 2023

August 24, 2023

Via Benzinga

Marijuana Stock Movers For August 23, 2023

August 23, 2023

Via Benzinga

Cannabis Stock Gainers And Losers From August 16, 2023

August 16, 2023

Via Benzinga

Marijuana Stock Movers For August 15, 2023

August 15, 2023

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.